Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a

  • Authors:
    • Zhan Sun
    • Bin Yan
    • Wen Yan Yu
    • Xueping Yao
    • Xiaojuan Ma
    • Geli Sheng
    • Qi Ma
  • View Affiliations

  • Published online on: July 13, 2016     https://doi.org/10.3892/etm.2016.3518
  • Pages: 1879-1884
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Doxorubicin (DOX) is one of the most effective chemotherapeutic drugs. However, its clinical use has been hampered due to the development of cardiotoxicity. Vitexin, which is the active ingredient of hawthorn leaf extract, has various biological activities, including antioxidant and anti‑inflammatory actions. The present study aimed to investigate whether vitexin was able to protect against DOX‑induced acute cardiotoxicity in model rats and the mechanisms of this protective effect were assessed. Adult Sprague‑Dawley rats were randomly assigned into the control (saline only), model (DOX only) and vitexin‑treated (DOX plus vitexin) groups. Rats in the model and vitexin‑treated groups were injected with DOX (2 mg/kg; i.p.) once a week for 4 weeks. Rats in the vitexin‑treated group were administered 30 mg/kg oral vitexin once daily at doses for 4 weeks. The levels of lactate dehydrogenase, creatine kinase isoenzyme-MB, malondialdehyde, superoxide dismutase, catalase and myeloperoxidase were assessed using assay kits. The levels of inflammatory mediators, including tumor necrosis factor‑α, interleukin (IL)‑1β, IL‑6, nuclear factor (NF)‑κB, and caspase-3, were assayed by the enzyme‑linked immunosorbent assay method. Western blot analysis was performed to assess the protein expression levels of p‑FOXO3a. Vitexin pretreatment significantly protected against DOX‑induced myocardial damage, which was characterized by increased serum creatine kinase isoenzyme‑MB and lactate dehydrogenase. Vitexin significantly ameliorated oxidative stress injury evoked by DOX, demonstrated by the inhibition of lipid peroxidation and the elevation of antioxidant enzyme activities. Furthermore, DOX provoked inflammatory responses by increasing the expression levels of IL‑1β, IL‑6, NF‑κB and tumor necrosis factor‑α, whereas vitexin pretreatment significantly inhibited these inflammatory responses. Notably, DOX induced apoptotic tissue damage by increasing caspase‑3 activity, whereas vitexin administration was able to decrease caspase-3 activity. In addition, vitexin induced elevated FOXO3a protein expression levels in the vitexin-treated group. In conclusion, the findings of the present study suggested that vitexin possesses cardioprotective action against DOX‑induced cardiotoxicity by suppressing oxidative stress, inflammation and apoptotic signals.
View Figures
View References

Related Articles

Journal Cover

September-2016
Volume 12 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sun Z, Yan B, Yu WY, Yao X, Ma X, Sheng G and Ma Q: Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a. Exp Ther Med 12: 1879-1884, 2016
APA
Sun , Z., Yan , B., Yu , W.Y., Yao , X., Ma , X., Sheng , G., & Ma , Q. (2016). Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a. Experimental and Therapeutic Medicine, 12, 1879-1884. https://doi.org/10.3892/etm.2016.3518
MLA
Sun , Z., Yan , B., Yu , W. Y., Yao , X., Ma , X., Sheng , G., Ma , Q."Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a". Experimental and Therapeutic Medicine 12.3 (2016): 1879-1884.
Chicago
Sun , Z., Yan , B., Yu , W. Y., Yao , X., Ma , X., Sheng , G., Ma , Q."Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a". Experimental and Therapeutic Medicine 12, no. 3 (2016): 1879-1884. https://doi.org/10.3892/etm.2016.3518